期刊语言：英语

出版地区：美国

万维提示

1、投稿方式：在线投稿。

2、期刊网址：http://www.bjui.org

https://bjui-journals.onlinelibrary.wiley.com/journal/1464410x

https://www.bjuinternational.com/

3、投稿网址：http://mc.manuscriptcentral.com/bjui

4、官网邮箱：editorial.office@bjui.info（编辑部）

5、期刊刊期：月刊，一年出版12期。

2022年1月4日星期二

投稿须知【官网信息】

BJU INTERNATIONAL

Author Guidelines

BJU INTERNATIONAL AUTHOR GUIDELINES

The Editor of BJUI welcomes original contributions on topics of interest and importance to urologists, whether written by urologists, nephrologists, radiologists, nurses or basic scientists. We are able to offer fast publication and encourage colour illustrations wherever appropriate.

EDITORIAL POLICIES AND PROCEDURES

Submission and Peer-review

Submissions are considered on the conditions that they are previously unpublished, and are not offered simultaneously elsewhere; that all authors have read and approved the content; that all authors have declared all competing interests; and that the work complies with the Ethical Policies of the Journal, and has been conducted under internationally accepted ethical standards after relevant ethical review. It is imperative that authors read this policy and complete any necessary documentation prior to your submission. When submitting a manuscript it is with the understanding that the manuscript (or its essential substance) has not been published other than as an abstract in any language or format and has not been submitted elsewhere for consideration for print or electronic publication.

This journal employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works.

The journal operates a stringent peer-review process. All manuscripts will be reviewed by the Editors, members of the Editorial Board, or other expert reviewers. At the discretion of the Editors, a manuscript may be returned immediately without full review, if deemed not competitive (for originality and quality) or outside the realm of interests of the majority of the readership of the Journal. Any statistical analyses will be assessed by a statistician. The decision (reject, revision, accept) letter will be conveyed through BJUI ScholarOne Manuscripts, coming directly from the Associate Editor who has assumed responsibility for the manuscript's review. If revision is requested the revised manuscript must be returned within two weeks for minor, or 6 weeks for major, revisions. If it is not submitted within this time frame, it may be treated as a new submission and may be sent out for review to different reviewers. Editorial decisions are based not just on the technical merit of the work, but also on other factors such as the priority for publication and the relevance to the Journal's general readership. All papers are judged in relation to other submissions currently under consideration. Acceptance of papers is based on the originality of the observation or investigation; the quality of the work described; the clarity of presentation; and the relevance to our readership. Rebuttals to rejected manuscripts are strongly discouraged and requests for resubmission of rejected manuscripts are generally not granted.

Publication Ethics

BJUI is a member of the Committee on Publication Ethics and subscribes to its recommendations (Committee on Publication Ethics [COPE]: guidelines on good publication practice, www.publicationethics.org.uk). Best Practice Guidelines on Publication Ethics are also available from https://authorservices.wiley.com/ethics-guidelines/index.html. The Editors reserve the right to reject a paper on ethical grounds. All authors are responsible for adhering to guidelines on good publication practice.

Guidelines for the reporting of health research

Authors are required to review and follow our guidelines for reporting statistics and creating tables and figures before submitting their manuscript to the BJUI. Authors whose manuscript is compliant with the guidelines and sent for peer-review can also expect a faster review process.

Please see BJUI Guidelines for Reporting Statistics:

https://bjui-journals.onlinelibrary.wiley.com/doi/full/10.1111/bju.14640

Please see BJUI Guidelines for Reporting of Figures and Tables for Clinical Research in Urology:

https://bjui-journals.onlinelibrary.wiley.com/doi/abs/10.1111/bju.15102

Authors should consult and follow the relevant guidelines for reporting health research data, such as the CONSORT guidelines for randomised, controlled trials, and the PRISMA statement for Systematic Reviews and Meta-Analyses. The Equator Network collects together key reporting guidelines for health research, including CONSORT and PRISMA.

BJUI requires registration of clinical trials in a public trials registry at or before the time of first patient enrolment as a condition of consideration for publication, in accordance with the ICMJE clinical trial registration policy. The ICMJE accepts registration in any registry that is a primary register of the WHO International Clinical Trials Registry Platform (ICTRP) or in ClinicalTrials.gov

…

更多详情：

https://bjui-journals.onlinelibrary.wiley.com/hub/journal/1464410x/homepage/forauthors.html